UCB Transforms Safety Operations with Veeva Safety Suite in Collaboration with ELIQUENT Life Sciences, Pinnaxis, and Daelight Solutions
WASHINGTON, June 12, 2026 /PRNewswire/ -- ELIQUENT Life Sciences ("ELIQUENT") today announced the June 1 go-live of Veeva Safety Suite at UCB. As one of the first organizations to adopt the complete suite, UCB is unifying its global safety...
From Chengdu to the World, Pernod Ricard, the worldwide leader in the spirits industry showcases Chinese Whisky "THE CHUAN" through Hong Kong
HONG KONG, June 12, 2026 /PRNewswire/ -- Pernod Ricard, the worldwide leader in the spirits industry, held the "From Chengdu to the World – Showcasing Chinese Whisky through Hong Kong: THE CHUAN" press conference today. The event was graced by the...
Akeso's Gumokimab (AK111, Anti-IL-17) Approved by NMPA for Moderate-to-Severe Plaque Psoriasis, Bolstering Its Autoimmune Disease Portfolio
HONG KONG, June 12, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced that the National Medical Products Administration (NMPA) of China has approved gumokimab (AK111), the company's internally-developed anti-IL-17 monoclonal antibody, for...
KT&G: "World's Largest Asset Manager BlackRock Increases stake from 5.01% to 6.15%"
- Foreign ownership rises to 51% based on strong overseas performance and enhanced shareholder returns - CEO Bang Kyung-man and senior management actively communicate with global investors through Overseas Non-Deal Roadshows (NDRs) SEOUL, South...
Elixiron Immunotherapeutics Reports Positive Phase 2 Interim Results for Enrupatinib: Evidence of Neuroinflammation Reduction and Early Cognitive Benefit in Alzheimer's Disease
CAMBRIDGE, Mass. and TAIPEI, June 11, 2026 /PRNewswire/ -- Elixiron Immunotherapeutics (TPEx: 7871), a clinical-stage biopharmaceutical company pioneering precision immunotherapy for neurodegenerative and autoimmune diseases, today announced...
ToolGen Opens Advanced Field Testing Facility in Osong, Completing 'Bench-to-Field' Commercialization Platform for Global SAF and Industrial Crop Markets
Establishes a regulatory-compliant, state-of-the-art Genome-Edited (GE) Crop Field Testing Facility to accelerate global commercialization. Enables comprehensive field evaluation of a diversified crop portfolio, including drought tolerance,...
San José Homeowners Can Now Earn More Than $500 a Year by Enrolling Their FranklinWH Battery to the Grid
FranklinWH joins San Jose Clean Energy's Peak Rewards for Smart Homes program, offering battery owners upfront incentives and ongoing bill credits for helping stabilize the local grid during peak demand. SAN JOSE, Calif., June 10, 2026 /PRNewswire/...
CIBF 2026 Anchors Global Value Chains to Power Next-Gen Energy Storage
TIANJIN, China, June 10, 2026 /PRNewswire/ -- The 18th China International Battery Fair (CIBF 2026) concluded its three-day run at the Shenzhen World Exhibition & Convention Center. As the leading global gathering for the battery industry in the...
Lynk Pharmaceuticals' Partner Formation Bio Doses First Participant in Phase 1 Trial of BLKR201 (originally designated as LNK01006), a CNS-Penetrant TYK2 Inhibitor
HANGZHOU, China, SHANGHAI and BOSTON, June 10, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on autoimmune and inflammatory diseases, today announced a...
Everest Medicines Enters into Exclusive Asia-Pacific Licensing Agreement with Vcare PharmaTech for Sumecigrel
SHANGHAI, June 9, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today...